 Roche United States pirfenidone medicines respiratory diseases companies IPF FDA Brisbane $8.3 merger Swiss $74 share cash medicine cause cure tissue lungs scarred European Union Canada breakthrough therapy Wells Fargo Co. global revenue Pulmozyme Xolair Sanofi GlaxoSmithKline Actelion Bloomberg commitment options families CEO shares commitment employees